SCHEMBL5709682

SCHEMBL5709682

C1CCN([C]2CC2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5709647 0.96
SCHEMBL204533 0.90 USP2 (0.44)
SCHEMBL28615280 0.90 USP2 (0.44)
SCHEMBL1828720 0.90 USP2 (0.44)
SCHEMBL206437 0.90 USP2 (0.44)
SCHEMBL6600866 0.90 USP2 (0.44)
SCHEMBL1824179 0.90 USP2 (0.44)
SCHEMBL15390690 0.90 USP2 (0.39)
SCHEMBL25357257 0.89
SCHEMBL1826475 0.86 INMT (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116640157-A METTL3 inhibitor and composition thereof and application of METTL3 inhibitor and composition thereof in medicine 海思科医药集团股份有限公司 2023-08-25 CN claimed
CN-116640157-A METTL3 inhibitor and composition thereof and application of METTL3 inhibitor and composition thereof in medicine 海思科医药集团股份有限公司 2023-08-25 CN disclosed
WO-2023151697-A1 METTL3 INHIBITOR AND COMPOSITION, AND APPLICATION OF SAME IN MEDICINE 四川海思科制药有限公司 2023-08-17 WO disclosed
CN-113330009-A Nitrogen heterocyclic compound, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-08-31 CN disclosed
CN-113316578-A Heterocyclic compounds, pharmaceutical compositions containing them, processes for their preparation and their use 四川科伦博泰生物医药股份有限公司 2021-08-27 CN disclosed
CN-113195469-A Nitrogen-containing heterocyclic compound, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-30 CN disclosed
CN-105263933-B A kind of simultaneously [1,2 a] benzazolyl compounds and preparation method thereof and the application in medicine of pyrazine 埃斯蒂维实验室股份有限公司 2017-12-22 CN disclosed
EP-1712227-A1 Amino diols useful in the treatment of Alzheimer's disease Elan Pharmaceuticals, Inc. (US) 2006-10-18 EP disclosed
US-20050080141-A1 Amino diols useful in the treatment of alzheimer's disease SCHOSTAREZ HEINRICH J (US) 2005-04-14 US disclosed
US-20040220272-A1 Propargyl glycine amino propargyl diol compounds for treatment of hypertension G.D. SEARLE & CO. 2004-11-04 US disclosed
US-5484811-A ADMINISTERING A RENIN INHIBITOR TO A SUBJECT G. D. SEARLE & CO. (US) 1996-01-16 US disclosed
US-5484812-A ADMINISTERING A RENIN INHIBITOR TO A SUBJECT G.D. SEARLE & CO. (US) 1996-01-16 US disclosed
EP-0610451-A1 ETHYNYL ALANINE AMINO DIOL COMPOUNDS FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1994-08-17 EP disclosed
US-5330996-A Renin inhibitors G. D. SEARLE & CO. (US) 1994-07-19 US disclosed
US-5227401-A ETHYNYL ALANINE AMINO DIOL COMPOUNDS FOR TREATMENT OF HYPERTENSION G. D. SEARLE & CO. (US) 1993-07-13 US disclosed
US-5223535-A Renin inhibitors G. D. SEARLE & CO. (US) 1993-06-29 US disclosed
WO-1993009108-A1 AMINO ACYL AMINO PROPARGYL DIOL COMPOUNDS FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1993-05-13 WO disclosed
WO-1993009086-A1 PROPARGYL GLYCINE AMINO PROPARGYL DIOL COMPOUNDS FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1993-05-13 WO disclosed
WO-1993009087-A1 ETHYNYL ALANINE AMINO DIOL COMPOUNDS FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1993-05-13 WO disclosed
EP-0539976-A1 Ethynyl-alanine-amino-diol compounds for treatment of hypertension G.D. Searle & Co. (US) 1993-05-05 EP disclosed